Yazar "Chan, Stephen Lam" seçeneğine göre listele
Listeleniyor 1 - 1 / 1
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Association of adverse events (AEs) with efficacy outcomes for cabozantinib (C) in patients (pts) with advanced hepatocellular carcinoma (aHCC) in the phase III CELESTIAL trial.(Amer Soc Clinical Oncology, 2019) Abou-Alfa, Ghassan K.; Meyer, Tim; Cheng, Ann-Lii; Cicin, Irfan; Bolondi, Luigi; Klumpen, Heinz Josef; Chan, Stephen Lam[Abstract Not Available]
